Minute Insight: Dexcom Next-Generation G7 CGM Approved In Canada

Dexcom wins Health Canada approval to market its G7 CGM in Canada, following announcements of its ambitious R&D map to expand into metabolic health and new product plans for consumers and the diabetes markets at ADA.

Minute Insight
• Source: Citeline/Alamy

DexCom, Inc. announced that Health Canada approved its next-generation G7 continuous glucose monitoring system.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Minute Insights

More from Medtech Insight